Comparing 4.0 mg.Kg-1 Sugammadex With Placebo in the Reversal of Profound Neuromuscular Blockade (P05767)

Clinical trial NCT00758485 · COMPLETED

Trial details

NCT number: NCT00758485
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Anesthesia Neuromuscular Blockade

Start date: 2008-10-01
Primary completion: 2009-05-01
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.